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Abstract: 
Occupational trichloroethylene (TCE) exposure can induce hypersensitivity dermatitis and 
severe liver injury. Recently, several clinical investigations indicate that viral infection, such 
as human herpesvirus-6, is associated with hepatic dysfunction in patients with TCE-related 
generalized skin disorders. However, whether viral infection aggravates TCE-induced liver 
injury remains unknown. This study aimed to explore the contribution of viral infection to the 
development of TCE-sensitization-induced liver injury in BALB/c mice. Female BALB/c 
mice were randomly assigned into four groups: solvent control group (n = 20), TCE group (n 
= 80), poly(I:C) group (n = 20) and combination of TCE and poly(I:C) injection 
(poly(I:C)+TCE) group (n = 80). Poly(I:C) (50μg) was i.p. administrated. TCE and 
poly(I:C)+TCE groups were further divided into sensitization and non-sensitization subgroup. 
Complement 3 and 3a protein levels, and complement factors were measured. Combination 
treatment significantly aggravated TCE-induced liver injury, decreased complement 3, but 
increased complement 3a in serum and liver tissues in sensitization group. These changes 
were not correlated with the hepatic complement 3 transcription. Moreover, combination 
treatment specifically promoted complement factor B, but not factor D and factor H 
expressions, in liver tissues. These data provide first evidence that Poly(I:C) potentiates liver 
injury in BALB/c mouse model of TCE-sensitization. Upregulated complement 3a and factor 
B contributes to the poly(I:C) action in TCE-induced liver injury. This new mode of action 
may explain increased risk of chemical-sensitization induced tissue damage by viral 
infection. 
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1. Introduction 
Trichloroethylene (TCE), a common industrial solvent, is used in large quantity in 
some developing countries. Increasing evidence from epidemiology and laboratory 
animal studies indicates that TCE is an immunotoxicant and capable of disrupting 
human immune homeostasis, which results in autoimmune disease or even severe 
hypersensitive skin disorder(Chiu et al., 2013). It is well known that TCE-induced 
hypersensitivity is clinically characterized by serious generalized hypersensitivity 
dermatitis, often accompanied by lethal liver dysfunction, occurring among workers 
after a period of occupational TCE exposure(Kamijima et al., 2007; Xu et al., 2009). 
The prevalence of this illness is estimated to be as high as 13% and the morality is 
about 9-13%(Kamijima et al., 2007). For effective prevention and clinical 
management, this life-threatening syndrome has been classified as occupational 
disease and is termed as Occupational Dermatitis Medicamentosa-like of 
Trichloroethylene (ODMLT)(Kamijima et al., 2007).  
Apart from the distinct cutaneous symptoms, epidemiological investigations show that 
the symptoms of infection such as fever and headache are frequently present in 
ODMLT patients at early stage(Xu et al., 2009). These clinical manifestations suggest 
that ODMLT may begin with infection. Interestingly, several studies have proposed 
that herpesvirus and cytomegalovirus are reactivated in a considerable proportion of 
the ODMLT cases with liver damage. Furthermore, the antibody titer against virus 
was significantly higher in the patients(Kamijima et al., 2013; Watanabe et al., 2010). 
Pathogenic invaders can act as danger signals by engaging pattern recognition 
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receptors (PRRs) and activating innate immune system, which results in the 
expression of pro-inflammatory cytokines(Bowie and Unterholzner, 2008). There is 
also evidence that adapted immune response, participates in the pathology of ODMLT, 
which can be activated and amplified by priming T cells and inducing antigen specific 
responses(Bowie and Unterholzner, 2008). Therefore it is possible that the original 
infection caused by virus may be involved in the initiation of the disease.  
Many studies suggest that complement system plays an important role in 
ODMLT(Huang et al., 2014; Yue et al., 2007; Zhao et al., 2012). The complement 
cascade can be activated by classical, alternative and lectin pathways and all these 
routes lead to the cleavage of the central molecule, complement component 3 (C3), to 
C3a and C3b(Kolev et al., 2014). The C3 is mainly synthesized by liver, although it 
has been suggested that almost all cells in the body have the capacity to generate 
complement proteins in human(Kolev et al., 2014). It is known that the level of C3 
dramatically decreases in serum during the early outset of disease and recovers to the 
normal level after a period of stay in the hospital following the admission among 
ODMLT patients(Huang et al., 2014). Moreover, the decrease of C3 was significantly 
associated with the extent of liver injury induced by TCE(Huang et al., 2014). 
Considering the biochemical process of C3 activation, these C3 changes may be 
attributed to the balance between C3 cleavage and production. There is report that 
increased breakdown of C3 can be detected in damaged liver tissue from 
TCE-sensitized mice with higher depositions of downstream complement fragments 
and the ultimate membrane attack complex(Wang et al., 2014; Zhang et al., 2013). In 
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addition, elevated levels of C3a-desArg in circulation are also observed with liver 
impairment in TCE-sensitized mice(Zhang et al., 2013). Furthermore, there is no clear 
evidence to suggest that hepatic C3 generation is suppressed among ODMLT cases. 
Therefore, we propose that excessive complement activation occurring during the 
progress of ODMLT, which may consume the circulated C3 protein and lead the 
declined serum C3 level, contribute to concurrent liver injury.  
In our previous studies, we have established a TCE sensitization model using BALB/c 
mouse, which will be used to explore the mechanism of liver injury induced by TCE 
(Wang et al., 2014; Wang et al., 2015). This TCE sensitization-induced liver injury 
only occurs in TCE sensitization-positive group and is characterized by hepatocyte 
swelling, deposition of cytokines, activation of complement system, mild increments 
of ALT and AST, and recovery when TCE exposure is ceased (Wang et al., 2014; 
Zhang et al., 2013). This pathological feature is different from classic liver injury 
commonly induced by hepatotoxicants via direct chemical toxicity.. In the present 
study, we hypothesize that the initial viral infection aggravates liver injury in 
TCE-sensitized BALB/c mice. Polyinosine-polycytidylic acid (polyI:C) is structurally 
similar to double-stranded RNA generated by virus and is widely used as a virus 
mimic in experimental studies(Cheng et al., 2009). Therefore, we employ polyI:C as a 
virus mimic to investigate whether it could exacerbate liver injury and activate C3 in 
TCE-sensitized BALB/c mice. 
2. Material and Methods 
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2.1 Treatments of Animals 
Female BALB/c mice (6-8 weeks) were purchased from the Experimental Animal 
Center of Anhui Province (Anhui, China) and maintained with a 12 h light/dark cycle 
in a controlled temperature (20–25 °C) and humidity (50 ± 5%) environment with free 
access to food and water. Animals were given one-week adaptation before the 
treatment. The dorsal hair of the mice was shaved with an area about 4 cm2 and 
remained bald throughout the experiment by shaving regularly. All experiments were 
performed in accordance with guidelines from Animal Care and Use Committee of 
Anhui Medical University. 
Workers are commonly exposed to TCE through direct skin contact. This route of 
exposure was mimicked by cutaneous application of TCE on mice. In TCE treatment 
group, chemical sensitization was induced according to our previous protocol(Wang et 
al., 2014; Wang et al., 2015; Zhang et al., 2013). Briefly, 80 mice were randomly 
assigned into four subgroups (n = 20 for each subgroup) of different time points (day 
20, 21, 22 and 26), and received the same treatment protocol as follows. On the first 
day, mice were intradermally injected with 100μl mixture of 50% TCE and Freund 
complete adjuvant (Sigma Aldrich, St. Louis, MO, USA) with the volume ratio of 1:1 
within the area of the naked back skin. The 50% TCE was prepared by mixing TCE, 
acetone and olive oil (all from Sigma Aldrich, St. Louis, MO, USA) with a volume 
ratio of 5:3:2. On day 4, 7 and 10, 100μl 50% TCE was painted on the same area and 
the area was then covered with a filter paper, secured by a non-irritating tape. On day 
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17 and 19, 30% TCE (TCE: acetone: olive oil= 3:5:2) was applied as the first and 
second challenge, respectively.  
Viral infection is closely associated with TCE-induced hypersensitivity 
syndrome(Kamijima et al., 2013; Watanabe et al., 2010; Xu et al., 2009), and this 
infection was mimicked by poly(I:C) injection, which is widely used as a simulation 
of viral infection in animal model(Cheng et al., 2009). In poly(I:C) and TCE 
cotreatment group, another 80 mice were randomly assigned into four subgroups of 
different time points (n = 20 for each subgroup) followed by the same treatment. 50μg 
polyI:C (Invivogen, San Diego, California, USA) was dissolved in 0.2ml sterile saline 
and then an intraperitoneal injection was given three hours before the second 
challenge (FIG 1). In order to ensure comparability, mice in TCE-treated group were 
also administrated with the same sterile saline as in other groups before the second 
challenge. In polyI:C control group, polyI:C and all the above solvents and saline 
were used. Solvent control group received only solvent and saline injections. 
On day 20, 21, 22 and 26, animals were euthanized according to the subgroup 
assigned. The cutaneous response was scored before euthanasia according to a 
four-point scale: 0 (no reaction), 1 (scattered mild redness), 2 (moderate and diffuse 
redness) and 3 (intensive erythema and swelling). If the score number was no less 
than one, the corresponding mouse was categorized as sensitized. Otherwise, it would 
be identified as non-sensitized.  
2.2 Evaluation of liver injury 
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For biochemical analysis, the blood sample was collected by retro-orbital puncture 
and placed under room temperature for two hours for clotting. The serum was 
separated by centrifugation at 10,000g for 15min and the supernatants were collected. 
The level of alanine aminotransferase (ALT) was determined by an automated 
biochemical analyzer. For histological pathology evaluation, tissue from the right lobe 
of the liver was taken and fixed in 4% neutral buffered formaldehyde overnight. The 
liver samples were then embedded in paraffin. The liver tissue block was sliced at 
5μm thickness, dewaxed and stained with hematoxylin and eosin for histological 
examination. The remaining fresh liver tissue was cryopreserved for subsequent 
experiments. 
2.3 ELISA assay 
Serum levels of C3, C3a, factor B, factor D and factor H were measured using 
respective commercial ELISA assay kits, and following manufacturer instructions 
(Elabscience, Wuhan, China). The optical density (OD) of each sample well was read 
at 450 nm using a microplate reader (BioTek, Winooski, VT, USA). 
2.4 Immunohistochemical detection and scoring 
For immunohistochemical assay, sliced tissue was dewaxed and rehydrated using the 
routine protocol. After antigen retrieval and endogenous peroxidase block, tissues 
were incubated with C3 antibody (MP Biomedicals Headquarters, Santa Ana, CA), 
C5b-9 antibody (Abcam, Cambridge, MA, USA), factor B antibody (Abcam, 
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Cambridge, MA, USA) overnight at 4°C. Thereafter, slides were incubated with 
horseradish peroxidase-labeled avidin-biotin complex (Dako, Carpinteria, CA, USA). 
The immuno-binding products were visualized by diaminobenzidine and 
counterstained by hematoxylin. To make a quantitative evaluation, two investigators 
independently took photos of 10 random visual fields under × 400 magnifications 
from each sample by microscopy (Olympus, Center Valley, PA, USA). 
Immunohistochemical staining was scored based on Histoscore (H-score). This 
involved a semiquantitative assessment of both the intensity of staining (graded as: 0, 
non-staining; 1, weak; 2, median; or 3, strong) and the percentage of positive cells. 
The values of scores ranged from 0 to 300. 
2.5 Total RNA Isolation and real-time RT-PCR 
Total RNA was extracted by using Trizol Reagent (Invitrogen, Grand Island, NY, 
USA) from liver homogenates. The cDNA was yielded with RevertAid First Strand 
cDNA Synthesis Kit (Thermo Scientific, Grand Island, NY, USA). Real-time 
qualitative PCR was performed using LightCycler 480 SYBR Green I Master (Roche 
Diagnostics GmbH, Mannheim, Germany) and the respective primers. Primer 
sequences are as follows: gapdh F’-ACC CCA GCA AGG ACA CTG AGC AAG, 
R’-GGC CCC TCC TGT TAT TAT GGG GGT; c3 F’-CAA CGC AAG TTC ATC 
AGC CA, R’-CAA CGC AAG TTC ATC AGC CA. The amplification reactions were 
conducted on LightCycler® 480 Instrument (Roche Diagnostics GmbH, Mannheim, 
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Germany). The PCR parameters were: 95 °C for 5 min, 40 cycles PCR (95 for 15 s, 
60 °C for 15 s, and 72 °C for 30 s).  
2.6 Statistical analysis 
All data were presented as mean ± standard deviation (SD). Two-tailed Student t test 
was used to compare two independent groups. Comparisons among multiple groups 
were performed by ANOVA with a post hoc test of significance between individual 
groups. P value less than 0.05 was considered to be statistically significant. 
3. Results 
3.1 PolyI:C potentiated the liver injury in TCE-sensitized BALB/c mice 
PolyI:C is structurally similar to double-stranded RNA generated by virus. Previous 
study indicates that i.p. injection of 50μg polyI:C alone into BALB/c mice does not 
cause apparent liver damage (Cheng et al., 2009). Therefore, we used this dose in the 
present study. As expected, administration of 50μg polyI:C alone (4 mice each day, n 
= 16) did not affect liver function (ALT: 15.30±3.76; 17.74±2.29; 14.34±3.58; 
18.66±1.22, at day 20, 21, 22 and 26 respectively:), which was comparable to solvent 
control group (4 mice for each day, n = 16; ALT: 19.56±3.24; 18.54±1.86; 18.49±5.37; 
17.42±2.31, at day 20, 21, 22 and 26 respectively). The normal histological 
micrographs in two control groups are shown in the supplement figure. TCE alone 
treatment resulted in about 33.3% sensitization rate and moderate liver impairment in 
the sensitized mice. The levels of ALT were mildly elevated in the TCE-sensitized 
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group, and peaked at 72 hours after the last challenge (FIG 2A). Histological 
pathology evaluation indicated that the swelling hepatocytes and neutrophil 
infiltration were occasionally identified in this tissue (FIG 2B). However, polyI:C and 
TCE cotreatment resulted in the sensitization rate of TCE reach to about 40% in 
BALB/c mice, although there was no statistical significance in comparison to TCE 
alone treatment group. In addition, the biochemical measurement indicated that the 
level of ALT in the sensitized mice from the polyI:C and TCE cotreatment group was 
significantly increased, when compared with that in the sensitized mice from the TCE 
alone treatment group, and peaked earlier at 48 hours (FIG 2A). In line with that, 
histological pathology evaluation also showed that there was severe and massive 
swelling and ballooning degeneration of hepatocytes with inflammatory cells 
infiltration in liver tissue(FIG 2B). Of note, these changes only occurred in 
sensitization positive groups and therefore suggested that the action was 
sensitization-specific. 
3.2 PolyI:C potentiated the decrease of serum complement 3 in TCE-sensitized 
BALB/c mice  
Several population investigations show that the level of serum C3 was dramatically 
decreased among ODMLT patients(Huang et al., 2014; Yue et al., 2007; Zhao et al., 
2012). Although serum C3 cannot be considered as truly hepatic, this protein is 
predominantly synthesized by liver in mouse and human (Fagerberg et al., 2014; 
Huang et al., 2014). Therefore, we tested the possibility that C3 decrease could have 
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been attributed to the severe liver injury, which impaired hepatic C3 generation. Our 
data also showed that the content of serum C3 significantly was reduced in sensitized 
mice of polyI:C and TCE cotreatment group, when compared with that in the 
sensitized mice from the TCE alone treatment group. The most significant reduction 
of C3 was observed at 48 hours. The effect only occurred in the sensitization-positive 
cotreatment group hence suggesting a sensitization-specific effect. Of note, TCE 
alone treatment was insufficient to reduce the content of C3 in serum (FIG 3A). In 
order to answer whether the ability of C3 production of the liver was damaged, we 
detected the expression of C3 at the transcriptional levels. Our results showed that 
there was no significant difference between any groups at each selected time point 
(FIG 3B). These data together suggest that C3 may play a role in PolyI:C potentiated 
the liver injury in TCE-sensitized BALB/c mice, and its decrease occurred at the 
post-transcription. 
3.3 PolyI:C enhanced TCE-induced complement 3a and factor B increases in 
serum 
A further possibility was that, excessive C3 cleavage could cause massive 
consumption of C3, thereby inducing apparent serum C3 reduction(Kolev et al., 2014). 
Therefore, we detected the level of C3 cleavage product, C3a, in serum at different 
times. The results showed that the level of C3a indeed dramatically increased in 
serum, which reached to the highest level at the same timer point i.e., at 48 hours, in 
sensitized mice from polyI:C and TCE cotreatment group. However, the level of C3a 
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only slightly elevated in TCE-sensitized group with a plateau from 48 to 72 hours 
(FIG 3C). 
Since factor B, factor D and factor H are considered to participate in the regulation of 
complement activation. We therefore determined the levels of factor B, factor D and 
factor H in the serum. As shown in FIG 4, the expression of factor B was up-regulated 
on day 1 and 2 by the cotreatment, whereas factor D and factor H showed no 
significant difference between each group at each selected time point. 
The above effects were again not observed in the sensitization-negative group under 
the cotreatment, therefore suggesting a sensitization-specific effect. 
3.4 Complement activation contributed to PolyI:C potentiation of TCE-induced 
liver injury 
Our previous studies indicated that local complement activation occurred in the mild 
liver injury induced by TCE sensitization(Wang et al., 2014; Zhang et al., 2013). To 
investigate whether the local complement activation also participated in PolyI:C 
potentiated, TCE-induced liver injury, we examined the depositions of C3 fragments 
and membrane attack complex (MAC) in the liver tissue. No apparent depositions of 
C3 fragments and membrane attack complex were observed in solvent and polyI:C 
alone treatment groups (see Supplement data). As shown in Figure 5 and 6, there were 
markedly increased depositions of C3 fragments and membrane attack complex in 
sensitized mice from polyI:C and TCE cotreatment group, in comparison with the 
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sensitized mice from TCE alone treatment group, suggesting complement was 
strongly activated in polyI:C and TCE cotreatment group. The effect was not seen 
with the co-treatment but sensitization-negative group. 
3.5 Hepatic complement factor B increase by PolyI:C potentiation. 
The increased expression of complement factor B was reported to promote the 
regional and systematic complement activation(Kaczorowski et al., 2012; Ostvik et al., 
2014; Schnabolk et al., 2015; Zou et al., 2013). Therefore, we hypothesized that the 
hepatic complement factor B generation was up-regulated in the polyI:C and TCE 
cotreatment group, which triggered excessive complement activation. As our results 
showed, no apparent factor B expression was found in solvent control and polyI:C 
group (See supplement data). The expression of factor B in the liver was however 
significantly increased in the sensitized mice from polyI:C and TCE cotreatment 
group, especially at 48 hours. This effect was again sensitization-specific as it was not 
seen with the cotreatment but sensitization-negative group. There were no apparent 
depositions of factor B in TCE only treatment group (FIG 7), emphasizing an 
interaction between poly I:C and TCE.  
4. Discussion 
Occupational TCE exposure may lead to generalized hypersensitive dermatitis and 
life-threatening complications such as serious liver injury (Kamijima et al., 2007; Xu 
et al., 2009). Clinical observations show that the symptoms of infection such as fever 
17  
 
and headache often occur at the early stage, which indicate that a preceding infection 
may contribute to the progress of this disease (Xu et al., 2009). In the present study, 
we pretreated the mice by i.p. injection of poly(I:C), a commonly used virus mimic 
due to the feature that it is structurally similar to viral double-stranded RNA, to mimic 
the systematic viral infection that would attack patients at early stage (Matsumoto and 
Seya, 2008). Our results firstly show that poly(I:C) potentiates the liver damage in 
mice following sensitization by TCE without affecting the sensitization rate, via a 
mechanism of activation of complement C3a and factor B. These findings 
demonstrate that virus infection contributes to TCE-induced liver damage through 
specific complement-dependent mechanisms. To our knowledge this is the first study 
to show that viral infection can precipitate the liver damage induced by chemical 
sensitization and this have important implications in understanding how 
environmental chemicals affect human body. 
It has been proposed that complement system plays an important role in TCE 
sensitization and the accompanied liver damage. Clinical evidence indicates that the 
serum level of complement 3 in ODMLT patients decreases dramatically during the 
early outset of the disease but recovers to normal level sometime after hospital 
admission (Huang et al., 2014). Moreover, the magnitude of C3 reduction is 
significantly associated with the severity of the liver injury (Huang et al., 2014). In 
the present study, our results showed that TCE treatment alone is inadequate to reduce 
the level of serum C3 content, while poly(I:C) and TCE cotreatment significantly 
reduced serum C3, suggesting an interaction between poly (I:C) and TCE. 
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Furthermore, we tested the possibility that clinical serum C3 suppression could have 
been attributed to the impaired C3 generation induced by severe liver injury. 
Interestingly, the transcriptional levels of C3 in liver tissue from each group were 
comparable, suggesting that aberrant C3 production was unlikely to have happened 
and participated in this phenomenon. Therefore, it is reasonable to postulate that the 
cotreatment-induced sensitization enhances complement activation, thus consuming 
more C3 molecule and resulting in the systemic C3 reduction. This would also predict 
that the activated form of C3, i.e., C3a would increase. As expected, significantly 
increased C3 fragments and MAC molecule were identified in liver tissue in the 
TCE-sensitized group. More importantly more intense and widespread depositions of 
these two proteins were detected in the cotreatment and sensitization-positive group. 
In addition, the levels of circulating C3a were also consistently elevated. Hence, 
excessive local complement activation may contribute to the circulating C3 reduction 
and the liver damage by TCE and its potentiation by poly (I:C). 
Previous studies document that up-regulation of complement factor B, factor D and 
factor H in both immune cells and parenchyma cells causes increased complement 
activation(Kaczorowski et al., 2010; Ostvik et al., 2014; Zou et al., 2013). In this 
study we subsequently investigated whether the generation of factor B, factor D and 
factor H was involved in this study. Our results showed that the expression of factor B, 
but not factor D and factor H, in the liver was significantly increased in the sensitized 
mice of poly(I:C) and TCE cotreatment group, while the its levels were comparable 
between TCE-sensitized group and control groups. This suggests that the different 
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levels of complement activation may be dependent on distinct mechanisms between 
the TCE-sensitized group and the cotreatment-sensitized group. The latter may be 
partly attributed to the up-regulation of factor B. TLRs-related pathways may be 
involved in this process. Studies show that inhibition of NF-κB and JNK signaling can 
completely or partially block the stimulation of factor B induced by poly(I:C) 
treatment in vitro (Kaczorowski et al., 2010). Trif knock-out mice also have reduced 
capacity to generate more factor B upon TLR4 activation (Zou et al., 2013). Moreover, 
MyD88 deletion entirely abolishes this ability caused by TLR2 stimulation(Zou et al., 
2013). However, in the present study, poly(I:C) alone application, which has been 
reported to initiate TLR3 signaling and subsequent factor B rise immune cells and 
parenchyma cells from several vitro experiments (Kaczorowski et al., 2010; Ostvik et 
al., 2014; Zou et al., 2013) and one in vivo experiment (Kaczorowski et al., 2010), did 
not cause factor B enhancement. This suggests that this effect is tissue-specific and 
may also reflect the difference between in vitro and in vivo conditions. Time of 
observation is another factor. Changes to factor B expression in immune and 
parenchyma cells were most apparent at 6-24 hours after TLR3 ligation in vitro 
(Kaczorowski et al., 2010; Ostvik et al., 2014; Zou et al., 2013) and peaked at 6 hours 
after poly (I:C) stimulation in vivo (Kaczorowski et al., 2010); therefore the level of 
this protein may have recovered after 24-48 hours under in vivo treatment as seen in 
our experiment. TCE treatment alone in our experiment did not cause a significant 
rise in factor B. However, the co-treatment caused an increase in factor B. This clearly 
shows that there is an interaction between poly (I:C) and TCE. Whilst Poly (I:C) may 
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have initially stimulated factor B increase to a sub-threshold level for detection, TCE 
could have enhanced and sustained the increase. Indeed, activation of MAPK and 
NF-κB pathways, which are crucial in promoting factor B synthesis (Kaczorowski et 
al., 2010), is identified in TCE-sensitized mice in our previous study (Zhang et al., 
2015). Thus, TCE sensitization may provide a favorable environment for sustained 
production of B stimulated by Poly (I:C) through MAPK and NF-κB pathways. 
It is interesting to note that all the co-treatment related changes in the present study 
occurred only in the co-treatment and sensitization positive group but not in the 
cotreatment whilst sensitization-negative group. This demonstrates that the effects by 
poly(I:C) and TEC interaction are sensitization-specific hence the immune responses. 
There is limited study on viral and chemical interactions in environmental chemical 
induced sensitization. There are observations that certain viral infection may 
aggravate asthma although the mechanisms are poorly understood (Kloepfer and Gern, 
2010). Our findings suggest that viral-chemical interaction may also apply to some 
other environmental chemicals. A better understanding of virus-aggravated 
sensitization by exposure to harmful environmental chemicals may lead to more 
effective public health strategy to limit chemical damage to the general population. 
In summary, poly(I:C) significantly potentiates the liver injury induced by TCE 
sensitization and decreases the level of serum complement C3, which is consistent 
with the clinical observations among ODMLT patients. Although poly(I:C) does not 
impair the ability of liver to generate C3, it causes massive complement activation and 
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its deposition in the liver tissue. Increased complement C3a and up-regulation of 
factor B are the underlying mechanisms for poly(I:C) potentiation of TCE 
sensitization-induced liver injury.
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Figure legends: 
Figure 1. Flow diagram of the treatment procedure. Initially, the hair on the back of 
female BALB/c mice was removed by shaving and then treated with intradermal 
injection of the mixture that consisted of 50μl 50% TCE (TCE: acetone: olive oil= 5: 
3: 2) and 50μl Freund complete adjuvant on day one. Then mice were sensitized by 
applying 100μl 50% TCE on the naked skin on day 4, 7 and 10. Subsequently the 
challenge phase was carried out by applying 100μl 30% TCE (TCE: acetone: olive 
oil= 3: 5: 2) on the naked skin on day 17 and 19. During this stage, 50μg poly(I:C) 
was i.p. injected 3 hours prior to the second administration at day 19. Finally, mice 
were classified into sensitized and non-sensitized ones according to the score of 
cutaneous response, followed by euthanasia and sacrifice on day 20, 21, 22 and 26. 
Figure 2. PolyI:C potentiated the liver injury in TCE-sensitized BALB/c mice. A) 
Serum ALT levels in different treatment groups; data showing TCE sensitization 
induced elevation of ALT and its augmentation by Poly I:C. B) Histopathological 
changes in the liver; representative microscopic pictures (magnification, 400×) of the 
HE staining showing widespread ballooning degeneration in the sensitized mice of the 
cotreatment group. Scale bar represented 50 μm. a P<0.05 compared with solvent 
group; b P<0.05 compared with sensitized mice in TCE group. Note: No histological 
changes were found in solvent and poly(I:C) and  
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groups and, in order to represent results more concisely and clearly, data and pictures 
of the two groups were not shown.  
Figure 3. Decreased circulation C3 and increased C3a in the sensitized mice of 
poly(I:C) and TCE cotreatment group. A) Serum levels of C3 (mean ± SD) in each 
group. B) Transcription of C3 in liver tissue by real-time RT-PCR. C) The level of 
C3a in the serum. a P<0.05 compared with solvent group; b P<0.05 compared with 
sensitized mice in TCE group. In order to represent the results more concise and clear, 
data from solvent and poly(I:C) groups were not shown.  
Figure 4. The expression of factor B, factor D and factor H in the serum by ELISA 
assay. The serum levels of factor B increased significantly in sensitized mice from 
cotreatment group at 24 and 48 hour. a P<0.05 compared with solvent group; b P<0.05 
compared with sensitized mice in TCE group. In order to represent the results more 
concise and clear, data from solvent and poly(I:C) groups were not shown.  
Figure 5. The expression of C3 fragments in the liver by immunohistochemistry. A) 
Sections from right liver lobe were incubated with anti-C3 antibody and this protein 
was visualized with diaminobenzidine. The representative microscopic pictures 
(magnification, 400×) were given from each group. Scale bar represented 50 μm. B) 
Immunohistochemical score of each group on each day. Bar represented the median 
score of a group. Note: No histological changes were found in solvent and poly(I:C) 
groups and data are shown in supplement file. 
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Figure 6. The expression of C5b-9 in liver tissue by immunohistochemistry. A) Liver 
tissue sections were incubated with anti-C5b-9 antibody and the binding was 
visualized with diaminobenzidine. The representative microscopic pictures 
(magnification, 400×) were presented from each group. Scale bar represented 50 μm. 
B) Immunohistochemical score of each group on each day. Bar represented the 
median score of a group. Note: No histological changes were found in solvent and 
poly(I:C) groups and data are shown in supplement file. 
Figure 7. Immunohistochemical detection of the expression of factor B in the liver. A) 
Liver sections were incubated with anti-factor B antibody and the protein-antibody 
complex was visualized with diaminobenzidine. The representative microscopic 
pictures (magnification, 400×) were shown from each group. Scale bar represented 50 
μm. B) Immunohistochemical score of each group on each day. Bar represented the 
median score of a group. Note: the solvent and poly(I:C) groups presented normal 
liver histology (data given in supplement file). 
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